Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
EHLD - Euroholdings Ltd - Stock Price Chart
TickerEHLD [NASD]
CompanyEuroholdings Ltd
CountryGreece
IndustryMarine Shipping
Market Cap15.50MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume64.96K52W Range6.11 - 37.59
Ribbon Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 17, 2024 and is headquartered in Tokyo, Japan.
AVR - Anteris Technologies Global Corp - Stock Price Chart
TickerAVR [NASD, RUT]
CompanyAnteris Technologies Global Corp
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap186.40MEPS (ttm)-2.12
P/E-EPS this Y43.77%
Forward P/E-EPS next Y1.87%
PEG-EPS past 5Y-
P/S69.04EPS next 5Y21.02%
P/B2.96EPS Q/Q-36.58%
Dividend-Sales Q/Q-1.48%
Insider Own0.12%Inst Own45.47%
Insider Trans0.00%Inst Trans54.35%
Short Float0.27%EarningsFeb 26
Analyst Recom1.25Target Price16.50
Avg Volume130.28K52W Range5.10 - 8.79
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seaberg John DDirectorMar 06 '25Option Exercise7.1340,000285,20040,000Mar 20 07:43 PM
Paterson WayneChief Executive OfficerMar 05 '25Option Exercise7.13233,0001,661,290233,000Mar 20 07:40 PM
Denaro StephenDirectorMar 11 '25Option Exercise7.1316,500117,64523,722Mar 20 07:35 PM
ADTX - Aditxt Inc - Stock Price Chart
TickerADTX [NASD]
CompanyAditxt Inc
CountryUSA
IndustryBiotechnology
Market Cap9.93MEPS (ttm)-245412.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y45.26%
P/S47.29EPS next 5Y-
P/B0.00EPS Q/Q94.31%
Dividend-Sales Q/Q-94.49%
Insider Own0.00%Inst Own0.03%
Insider Trans-Inst Trans-
Short Float3.80%Earnings-
Analyst Recom1.00Target Price610000.00
Avg Volume3.02M52W Range4.11 - 54500.00
Mar-18-25 07:22AM Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update (GlobeNewswire) +71.62%
Mar-17-25 08:15AM Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025 (Business Wire) -13.03%
Mar-12-25 04:15PM Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 (Business Wire) -5.33% -41.20%
Mar-06-25 08:15AM Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S. (Business Wire) -13.30%
Feb-22-25 08:45AM Aditxt subsidiary Persanta engages Dominary Securities for IPO (TipRanks)
Feb-21-25 08:15AM Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025 (Business Wire) -22.98%
Feb-13-25 08:15AM Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time (Business Wire) -17.87%
Jan-13-25 08:15AM Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform (Business Wire) -8.24%
Dec-12-24 08:15AM Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials (Business Wire)
Nov-19-24 07:17AM Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. (GlobeNewswire)
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRT FINANCIAL LP10% OwnerOct 15 '24Buy1.5015,63623,45425,434Oct 17 01:58 PM
HRT FINANCIAL LP10% OwnerOct 16 '24Sale1.1725,53429,8750Oct 17 01:58 PM
USAU - U.S. Gold Corp - Stock Price Chart
TickerUSAU [NASD]
CompanyU.S. Gold Corp
CountryUSA
IndustryGold
Market Cap129.36MEPS (ttm)-1.36
P/E-EPS this Y-8.11%
Forward P/E-EPS next Y15.00%
PEG-EPS past 5Y29.90%
P/S-EPS next 5Y-
P/B7.32EPS Q/Q-199.72%
Dividend-Sales Q/Q-
Insider Own14.05%Inst Own14.30%
Insider Trans0.00%Inst Trans23.74%
Short Float1.30%EarningsNov 27
Analyst Recom1.00Target Price16.73
Avg Volume218.24K52W Range3.46 - 11.75
U.S. Gold Corp. engages in the exploration of gold properties. It has properties in CK Gold Project, Wyoming, Challis Gold Project, Idaho, and Keystone, Nevada. The company was founded in 1967 and is headquartered in Elko, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bee George MCEO, PresidentMay 22 '24Buy5.903,37119,883401,016May 24 06:06 AM
Bee George MCEO, PresidentMay 15 '24Buy5.073,93919,982397,645May 16 03:19 PM
Bee George MCEO, PresidentMay 13 '24Buy4.704,17919,651393,706May 15 03:46 PM
NORMAN LUKE ANTHONYDirectorApr 15 '24Buy4.195,00020,950348,980Apr 17 02:33 PM
TNON - Tenon Medical Inc - Stock Price Chart
TickerTNON [NASD]
CompanyTenon Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap3.14MEPS (ttm)-14.48
P/E-EPS this Y69.98%
Forward P/E-EPS next Y60.06%
PEG-EPS past 5Y-25.43%
P/S0.96EPS next 5Y-
P/B1.41EPS Q/Q176.14%
Dividend-Sales Q/Q-4.70%
Insider Own0.00%Inst Own2.76%
Insider Trans-Inst Trans75.47%
Short Float5.29%EarningsMar 20/a
Analyst Recom1.00Target Price3.00
Avg Volume948.08K52W Range0.95 - 15.79
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.
MRT - Marti Technologies Inc - Stock Price Chart
TickerMRT [AMEX]
CompanyMarti Technologies Inc
CountryTurkey
IndustrySoftware - Application
Market Cap164.61MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y27.06%
P/B-EPS Q/Q248.15%
Dividend-Sales Q/Q-
Insider Own64.88%Inst Own12.48%
Insider Trans0.00%Inst Trans116.41%
Short Float0.51%EarningsFeb 26
Analyst Recom3.00Target Price3.00
Avg Volume49.94K52W Range0.71 - 3.89
Marti Technologies, Inc. engages in the provision of tech-enabled urban transportation services to riders across Turkiye. It operates through the Ride-Hailing and Two-Wheeled Electric Vehicle Rentals segments. The Ride-Hailing segment focuses on the service which matches riders with drivers traveling in the same direction to share car and motorcycle rides. The Two-Wheeled Electric Vehicle Rentals segment includes electric scooter, electric bike, and electric moped rental services. The company was founded by Cankut Durgun and Oguz Alper Oktem in 2018 and is headquartered in Istanbul, Turkey.
ELUT - Elutia Inc - Stock Price Chart
TickerELUT [NASD]
CompanyElutia Inc
CountryUSA
IndustryMedical Devices
Market Cap165.24MEPS (ttm)-2.48
P/E-EPS this Y58.60%
Forward P/E-EPS next Y38.31%
PEG-EPS past 5Y-10.72%
P/S6.78EPS next 5Y-
P/B-EPS Q/Q60.62%
Dividend-Sales Q/Q-6.93%
Insider Own38.70%Inst Own29.98%
Insider Trans3.99%Inst Trans35.91%
Short Float0.27%EarningsMar 06/a
Analyst Recom1.00Target Price9.00
Avg Volume41.96K52W Range2.28 - 5.24
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women's Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women's Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HighCape Capital, L.P.DirectorFeb 03 '25Buy2.50420,0001,050,0009,520,232Mar 13 04:30 PM
HighCape Capital, L.P.DirectorFeb 03 '25Buy2.50420,0001,050,0009,520,232Mar 13 04:28 PM
Ferguson MatthewCHIEF FINANCIAL OFFICERJul 31 '24Option Exercise1.43105,080150,002257,823Jul 31 05:00 PM
ATER - Aterian Inc - Stock Price Chart
TickerATER [NASD]
CompanyAterian Inc
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap18.56MEPS (ttm)-1.70
P/E-EPS this Y19.05%
Forward P/E-EPS next Y6.62%
PEG-EPS past 5Y49.72%
P/S0.19EPS next 5Y-
P/B0.62EPS Q/Q84.83%
Dividend-Sales Q/Q-24.87%
Insider Own19.14%Inst Own8.63%
Insider Trans-0.32%Inst Trans1.33%
Short Float3.39%EarningsMar 18/a
Analyst Recom1.00Target Price6.00
Avg Volume964.45K52W Range1.86 - 3.95
Aterian, Inc. is a technology enabled consumer products company. The company's brands include hOme, Vremi, Xtava and RIF6. Its product categories include home and kitchen appliances, kitchenware, environmental appliances, beauty related products and consumer electronics. The company was founded by Yaniv Sarig Zion in 2014 and is headquartered in Summit, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zahut Roi ZionChief Technology OfficerDec 13 '24Sale2.353,6948,681197,800Dec 16 09:00 PM
Lepper PhillipChief Revenue OfficerDec 13 '24Sale2.351,7114,021177,934Dec 16 09:00 PM
Rodriguez ArturoChief Executive OfficerSep 11 '24Sale3.0710,32531,698531,588Sep 13 08:32 PM
Zahut Roi ZionChief Technology OfficerSep 11 '24Sale3.0614,05042,993201,494Sep 13 08:31 PM
Lepper PhillipChief Revenue OfficerSep 11 '24Sale3.067,72123,626179,645Sep 13 08:31 PM
CTSO - Cytosorbents Corp - Stock Price Chart
TickerCTSO [NASD]
CompanyCytosorbents Corp
CountryUSA
IndustryMedical Devices
Market Cap53.93MEPS (ttm)-0.36
P/E-EPS this Y56.25%
Forward P/E-EPS next Y16.07%
PEG-EPS past 5Y-2.64%
P/S1.43EPS next 5Y39.75%
P/B4.12EPS Q/Q79.30%
Dividend-Sales Q/Q6.58%
Insider Own19.47%Inst Own27.95%
Insider Trans0.48%Inst Trans-3.42%
Short Float4.19%EarningsMar 31/a
Analyst Recom2.00Target Price5.50
Avg Volume259.64K52W Range0.70 - 1.61
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIANI PETER JChief Financial OfficerDec 13 '24Buy0.9620,00019,294401,363Dec 16 07:00 AM
MARIANI PETER JChief Financial OfficerDec 12 '24Buy0.8920,00017,872381,363Dec 13 08:00 AM
MARIANI PETER JChief Financial OfficerDec 11 '24Buy0.8911,36310,103361,363Dec 13 08:00 AM
DHX - DHI Group Inc - Stock Price Chart
TickerDHX [NYSE]
CompanyDHI Group Inc
CountryUSA
IndustrySoftware - Application
Market Cap71.92MEPS (ttm)0.00
P/E326.67EPS this Y66.67%
Forward P/E44.10EPS next Y99.99%
PEG-EPS past 5Y-52.96%
P/S0.51EPS next 5Y-
P/B0.62EPS Q/Q-53.73%
Dividend-Sales Q/Q-6.71%
Insider Own16.45%Inst Own62.35%
Insider Trans-0.34%Inst Trans-6.01%
Short Float0.42%EarningsFeb 05/a
Analyst Recom1.00Target Price4.88
Avg Volume183.09K52W Range1.45 - 3.32
DHI Group, Inc. engages in the provision of artificial intelligence-powered software products, online tools, and talent acquisition services, delivering career marketplaces to candidates for technology-focused roles and employers hiring tech talent globally. The company was founded in 1990 and is headquartered in Centennial, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LESSER EVANOfficerFeb 28 '25Proposed Sale2.221,5003,330Feb 28 04:30 PM
Swann Kathleen M.DirectorFeb 12 '25Sale2.9610,00029,600118,113Feb 13 04:33 PM
LESSER EVANOfficerFeb 13 '25Proposed Sale3.253,0009,750Feb 13 04:12 PM
Swann Kathleen M.DirectorFeb 12 '25Proposed Sale2.9610,00029,630Feb 12 04:13 PM
LESSER EVANOfficerFeb 06 '25Proposed Sale3.003,0009,000Feb 06 04:11 PM
123456789101120